International – WHO reviewing hydroxychloroquine safety data

The World Health Organization (WHO) on Tuesday promised a swift review of data on hydroxychloroquine, probably by mid-June, after safety concerns prompted the group to suspend the malaria drug’s use in a large trial on COVID-19 patients.

U.S. President Donald Trump and others have pushed hydroxychloroquine as a coronavirus treatment, but the WHO on Monday called time after the British journal The Lancet reported patients getting hydroxychloroquine had increased death rates and irregular heartbeats.

“A final decision on the harm, benefit or lack of benefit of hydroxychloroquine will be made once the evidence has been reviewed,” the body said. “It is expected by mid-June.”…